To determine whether SLC1A5 is a key downstream target of FTO promoting glutamine reprogramming, growth, and survival in ccRCC cells, we ectopically expressed SLC1A5 in FTO knockdown cells (Fig. 4A). The gene discussed is FTO; the disease is nonpapillary renal cell carcinoma.